RT Journal Article
SR Electronic
T1 Probability of elimination for COVID-19 in Aotearoa New Zealand
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.10.20172361
DO 10.1101/2020.08.10.20172361
A1 Binny, Rachelle N.
A1 Hendy, Shaun C.
A1 James, Alex
A1 Lustig, Audrey
A1 Plank, Michael J.
A1 Steyn, Nicholas
YR 2020
UL http://medrxiv.org/content/early/2020/08/11/2020.08.10.20172361.abstract
AB On 25th March 2020, New Zealand implemented stringent lockdown measures (Alert Level 4, in a four-level alert system) with the goal of eliminating community transmission of COVID-19. Once new cases are no longer detected over consecutive days, the probability of elimination is an important measure for informing decisions on when certain COVID-19 restrictions should be relaxed. Our model of COVID-19 spread in New Zealand estimates that after 2-3 weeks of no new reported cases, there is a 95% probability that COVID-19 has been eliminated. We assessed the sensitivity of this estimate to varying model parameters, in particular to different likelihoods of detection of clinical cases and different levels of control effectiveness. Under an optimistic scenario with high detection of clinical cases, a 95% probability of elimination is achieved after 10 consecutive days with no new reported cases, while under a more pessimistic scenario with low case detection it is achieved after 22 days.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Ministry of Business, Innovation and Employment and Te Pūnaha Matatini, New Zealand's Centre of Research Excellence in complex systems.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approval or exemption for this research was required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis article does not present new data.